Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04548609 · ClinicalTrials.gov registry record · NA

Transcranial Direct Current Stimulation (tDCS) in Pediatric Obsessive Compulsive Disorder (OCD)

A NA study, sponsored by Massachusetts General Hospital.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT04548609: Clinical Trial NA study, sponsored by Massachusetts General Hospital.

NCT04548609 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04548609, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

In this study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in modulating aberrant neurocognitive processes implicated in pediatric patients with obsessive compulsive disorder (OCD).

Interventions

  • DEVICE Transcranial Direct Current Stimulation

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2021-01-25
Est. Completion 2025-03-05
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT04548609

The ClinicalTrials.gov registry entry for NCT04548609 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Transcranial Direct Current Stimulation is the first listed.

NCT04548609 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04548609 about?

NCT04548609 is a clinical study titled "Transcranial Direct Current Stimulation (tDCS) in Pediatric Obsessive Compulsive Disorder (OCD)". In this study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in modulating aberrant neurocognitive processes implicated in pediatric patients with obsessive compulsive disorder (OCD).

What is the current status of trial NCT04548609?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-01-25. Estimated completion is 2025-03-05.

What interventions are being tested in trial NCT04548609?

The interventions under investigation include: Transcranial Direct Current Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04548609?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.